Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Human Growth Hormone Market In 2029?
The market size for human growth hormone has witnessed robust growth in the past few years. Market projections indicate an increase from $4.75 billion in 2024 to $5.18 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. Factors such as a growing number of growth disorders, heightened awareness of hormone therapies, its rising use in sports medicine, an expanding elderly population, and improvements in healthcare infrastructure have all contribute to its historical growth.
The market for human growth hormone is anticipated to experience significant expansion in the coming years, with projections estimating it will reach $7.32 billion in 2029, boasting a compound annual growth rate (CAGR) of 9.0%. This anticipated growth in the forecast period is linked to factors such as the rise of personalized medicine, increased global healthcare expenditure, higher usage of recombinant DNA technology, increased demand for hormone replacement therapies and a growing number of endocrine disorders. Future market trends predict an expansion of distribution networks in developing markets, incorporation of artificial intelligence in drug development, a focus on sustainable manufacturing practices, the creation of long-lasting formulations, and the use of combination therapies for improved efficacy.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Human Growth Hormone Market?
The anticipated expansion of the human growth hormone market can be attributed to enhanced understanding of treatment procedures. These procedures, designed to manage, alleviate or cure health-related issues, indicate technological advancements in medicine, improved information accessibility via digital media, and a rising public focus on health and wellness. Considerable media coverage and public fascination have been given to human growth hormone (HGH) treatments, underscoring the advantages and potential uses of cutting-edge medical interventions and consequently amplifying overall procedure awareness. For example, The 2022 National Survey on Drug Use and Health (NSDUH) compiled by Substance Abuse and Mental Health Services Administration (SAMHSA), a US Department of Health and Human Services division, illustrates this in a report from November 2023. The report stated that in 2021, 40.6% of the 5.0 million adolescents aged 12 to 17 with a past year Major Depressive Episode (MDE) underwent depression treatment, and in 2022, 56.8% of the 4.8 million adolescents with an MDE experience from the past year sought mental health treatment. Therefore, the expanding understanding of treatment procedures propels the growth of the human growth hormone market.
Which Key Market Segments Comprise the Human Growth Hormone Market and Drive Its Revenue Growth?
The human growth hormonemarket covered in this report is segmented –
1) By Product: Liquid; Powder
2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands
3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy
5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications
Subsegments:
1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone
2) By Powder: Reconstitutable Powder; Freeze-Dried Powder
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15825&type=smp
Which Areas Are Leading Regions in the Human Growth Hormone Market Expansion Across the Globe?
North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Key Market Trends in theHuman Growth Hormone Market Over the Coming Years?
Leading entities in the human growth hormone market are intensifying their concentration on the development of drugs and winning their approvals to enhance their medicinal offerings, as well as to deliver superior treatment options. The drug development procedure is intricate and painstaking, encompassing several phases to confirm the safety, effectiveness, and quality of a new product before it is introduced into the market. For example, in June 2023, Pfizer Inc., an American biopharmaceutical entity, alongside OPKO Health Inc., a biopharmaceutical and diagnostic company also from the US, declared that NGENLA (somatrogon-ghla) had been approved by the Food and Drug Administration (FDA). This therapy offers an improved dosing schedule, improving the patient’s ability to comply with their treatment compared to daily injections. It presents children suffering from growth hormone deficiency an option to reduce their injection frequency from daily to weekly. The approval of the FDA was backed by the data of a Phase 3 clinical trial, demonstrating the non-inferiority of NGENLA compared to the once-daily somatropin, bearing a similar safety profile to somatropin.
View the full report here:
https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report
How Is the Human Growth Hormone Market Conceptually Defined?
Human growth hormone (HGH) is a peptide hormone naturally produced by the pituitary gland that is crucial for stimulating growth, cell reproduction, and tissue regeneration throughout the human body. It is used in medical treatments for growth hormone deficiency, fostering muscle development, and addressing age-related concerns such as muscle wasting and bone density decline.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15825
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model